The Gowan Company has completed the acquisition of Ceradis, integrating the Netherlands-based innovator into the Gowan Group. This alliance combines Gowan’s global strength in crop protection and seeds with Ceradis’ expertise in the formulation, development and registration of crop protection compounds, expanding innovative solutions for growers worldwide.

• -  Strengthens Gowan’s global presence in Europe and the Americas.
•  
• -  Expands the portfolio of research, development and innovative formulations.
•  
• -  Reinforces the commitment to growers by providing greater technical support and tailored solutions.

“This acquisition strengthens Gowan’s long-term strategy of building a diversified, sustainable crop protection portfolio,” said Rob Plaice, global head of R&D.” 

Ceradis’s unique biocontrol solutions and forward-thinking formulation technology align well with Gowan and our future. Their bio‑mineral technologies expand our ability to deliver integrated disease management programs that combine conventional chemistry with natural mineral solutions. These multi-site mode-of-action products help preserve the effectiveness of key active ingredients, align with global sustainability trends and ensure growers have durable solutions for the future.”

“Joining Gowan marks the beginning of an exciting new chapter for Ceradis,” said Willem-Jan Meulemeesters, CEO of Ceradis. “Gowan shares our deep commitment to innovation, sustainability and providing growers with practical, science-driven solutions. Together, we will expand the reach of our biocontrol offerings, accelerating the adoption of more sustainable disease management strategies worldwide.”

Ceradis will continue operating from its headquarters in Wageningen, Netherlands, while integrating into Gowan’s global network. 

Source:  Gowan October 2, 2025 news release